Subscribe FREE to: Magazine | Newsletter | Linked In | Twitter Facebook


ODT Magazine


Search  


Latest News



ODT Magazine - RODMAN PUBLISHING CORP. Get it on Google Play


MediPlast Buys Orthoplastics Ltd.




MedPlast Inc. has acquired Orthoplastics Ltd. Orthoplastics is a Lancashire, United Kingdom-based custom manufacturer of ultra-high molecular weight polyethylene (UHMWPE) products and components for OEMs serving the orthopedic device implant market.

In addition to supplying UHMWPE material, Orthoplastics also produces implantable orthopedic components to customer specifications.

"Through this acquisition, MedPlast can accelerate its growth into the medical device assembly and implantables markets," Harold Faig, CEO of MedPlast, said. "The combination of MedPlast and Orthoplastics represents tremendous opportunities for both firms and for our customers."

According to MedPlast officials, Orthoplastics will gain production capacity for components, while MedPlast will benefit from an expanded footprint in Europe for medical applications.

"Orthoplastics becomes a key part of our strategy to deliver comprehensive processing technologies to the global medical device market," said Matt Langton, executive vice president of sales and marketing for MedPlast. "This will provide our current and future customers with a wider range of capabilities that become even more valuable as the design of medical products grows increasingly sophisticated and regulated.

"This acquisition allows MedPlast to combine its technical capabilities with Orthoplastics' implantable technologies to become a significant player in the implantable market," added David Brooks, managing director of Orthoplastics.

MedPlast has expertise in injection molding, medical blow molding, silicone extrusion, compression and transfer molding, liquid injection molding, two-shot molding, over molding, insert molding, multi-component molding, and precision mold making.

Orthoplastics has developed technology to produce premium grade UHMWPE material, as well as patenting a method of gamma cross linking in bulk with close dosage control, which is important to orthopedic device customers. Orthoplastics capabilities include direct compression molding, ram extrusion, annealing, machining and finishing, inspection and laboratory testing.

"Driven by an increasingly aging population and healthcare legislation, MedPlast's robust product line addresses the need for effective orthopedic solutions in both developed and developing countries," said Faig.

Terms of the deal were not disclosed.

MedPlast is headquartered in Tempe, Ariz. Its U.S.-based facilities are in Tempe, as well as Chicopee, Mass.; Elkhorn, Wis.; Fremont, Calif.; West Berlin, N.J.; Westfield, Pa.; and Monticello, Iowa.The company also has operations in Suzhou, China, and Tijuana, Mexico.



Copyright © 2014 Rodman Media. All Rights Reserved. All rights reserved. Use of this constitutes acceptance of our Privacy Policy
The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.